Browsing byAuthorJardine, MJ

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 2 to 6 of 6< previous 
Issue DateTitleAuthor(s)
2023-09-30Duration and effectiveness of glucose-lowering regimens in the real world management of diabetes: Data from the Australian EXTEND45 Linked Cohort StudyYoung, TK; Hockham, C; Sukkar, L; Kang, A; Jun, M; Foote, C; Baker, J; Rogers, K; Zoungas, S; Cass, A; Sullivan, D; Jardine, MJ
2021-09Effect of Hemodiafiltration on the Progression of Neuropathy with Kidney Failure: A Randomized Controlled Trial.Kang, A; Arnold, R; Gallagher, M; Snelling, P; Green, J; Fernando, M; Kiernan, MC; Hand, S; Grimley, K; Burman, J; Heath, A; Rogers, K; Bhattacharya, A; Smyth, B; Bradbury, T; Hawley, C; Perkovic, V; Krishnan, AV; Jardine, MJ; FINESSE Steering Committee,
2022-05-17Effect of Oral Methylprednisolone on Decline in Kidney Function or Kidney Failure in Patients With IgA Nephropathy: The TESTING Randomized Clinical Trial.Lv, J; Wong, MG; Hladunewich, MA; Jha, V; Hooi, LS; Monaghan, H; Zhao, M; Barbour, S; Jardine, MJ; Reich, HN; Cattran, D; Glassock, R; Levin, A; Wheeler, DC; Woodward, M; Billot, L; Stepien, S; Rogers, K; Chan, TM; Liu, Z-H; Johnson, DW; Cass, A; Feehally, J; Floege, J; Remuzzi, G; Wu, Y; Agarwal, R; Zhang, H; Perkovic, V; TESTING Study Group,
2019-03-01Hyperkalemia and renin-angiotensin aldosterone system inhibitor therapy in chronic kidney disease: A general practice-based, observational studyJun, M; Jardine, MJ; Perkovic, V; Pilard, Q; Billot, L; Rodgers, A; Rogers, K; Gallagher, M
2022-05Risk factors for incident kidney disease in older adults: an Australian prospective population-based study.Kang, A; Sukkar, L; Hockham, C; Jun, M; Young, T; Scaria, A; Foote, C; Neuen, BL; Cass, A; Pollock, C; Comino, E; Lung, T; Pecoits-Filho, R; Rogers, K; Jardine, MJ; EXTEND45 Study Steering Committee†,